96 Tests PN: A112224
32 Tests PN: A112224T
45x Ab-conjugated beads (S4P10 - human IL-8 ab-bead).
96 Tests PN: A112224A. One vial containing 100 µL of anti-human IL-8 conjugated to AimPlex Bead S4P10
32 Tests PN: A112224TA. One vial containing 35 µL of anti-human IL-8 conjugated to AimPlex Bead S4P10
25x Biotin-detection Ab (human IL-8 Biotin-dAb).
96 Tests PN: A112224B. One vial containing 100 µL of biotinylated anti-human IL-8
32 Tests PN: A112224TB. One vial containing 35 µL of biotinylated anti-human IL-8
Lyophilized Standard Mix-Human Group 1 Panel Panel B.
96 & 32 Tests PN: HG10011. One vial containing lyophilized recombinant Eotaxin, IL-1β, IL-1RA, IL-8, IL-12p70, IL-22, IP-10, MCP-1, MCP-3, and RANTES. Note: If multiple analyte kits on the above target list are ordered as a panel, only one vial of standard mix is supplied for those analyte kits.
Application: Optimal antibody pair and antigen standard for assaying human IL-8/CXCL8. Can be multiplexed with other analytes in Human Group 1. To be used in conjunction with the AimPlex NR Basic Kit (96 Tests PN: P100001, 32 Tests PN: P100001T)) and a diluent kit. Refer to the AimPlex Multiplex Immunoassay User Manual and kit inserts for the assay procedure.
Storage: 2-8 C in the dark.
Important: Sodium azide forms explosive compounds with heavy metals. These products contain <0.05% (w/w) azide which with repeated contact with lead and copper commonly found in plumbing drains may result in the buildup of shock sensitive compounds. Dispose in accordance with regulations from your institute.
For Research Use Only. Not for use in diagnostic procedures.
Sample types: Cell culture supernatant, serum, plasma, bodily fluid and tissue/cell lysate
Sensitivity (LOD): < 1 pg/mL
LLOQ: < 1 pg/mL
ULOQ: > 1,000 pg/mL
Standard dose recovery: 70-130%
Intra-assay CV: < 10%
Inter-assay CV: < 20%
Cross-reactivity of analytes in Human Group 1: Negligible
Sample volume: 15 µL/test
Interleukin-8 (Accession P10145) is a member of the CXC chemokine family produced by a variety of blood and tissue cells. It has a specificity for neutrophils and very little effect on other blood cells. IL-8 targets neutrophils to migrate towards the site of infection and induces phagocytosis on arrival. Aberrant production of IL-8 can suggest many different chronic inflammatory conditions, as it may inhibit typical neutrophil function. IL-8 does contribute to more beneficial proinflammatory activities such as angiogenesis and immune cell activation. There are correlations to palmoplantar pustulosis and atherosclerosis.
Bicket M. The role of interleukin-8 in inflammation and mechanisms of regulation. J. Periodontol. 1993; 64(5): 256-260. PMID: 8315568.
Gerszten, RE, Garcia-Zepeda EA, Lim Y, Yoshida M, Ding HA, Gimbrone Jr MA, Luster AD, Luscinskas FW, Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature. 1999; 398: 718-723. Doi: 10.1038/19546.
Skov L, Beurskens FJ, Zachariae COC, Reitamo S, Teeling J, Satijn D, Knudsen KM, Boot EPJ, Hudson D, Baadsgaard O, Parren PWHI, van de Winkel JGJ. IL-8 as Antibody Therapeutic Target in Inflammatory Diseases: Reduction of Clinical Activity in Palmoplantar Pustulosis. J Immunol. 2008; 181 (1): 669-679. Doi:10.4049/jimmunol.181.1.669.